A Review of Quinazoline-Based EGFR/VEGFR-2 Dual Inhibitors as Potent Anticancer Agents: Structure-Activity Relationship and Docking Studies
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase (RTK) that initiates various signaling pathways resulting in processes such as gene expression, proliferation, angiogenesis, and inhibition of apoptosis. Dysregulation of EGFR signaling causes tumor development and metastasis....
| Published in: | Pharmaceutical Sciences |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2025-01-01
|
| Subjects: | |
| Online Access: | https://ps.tbzmed.ac.ir/PDF/ps-31-43.pdf |
